Neuland Laboratories in Focus After ₹126 Cr Expansion Bet

Neuland Laboratories is in focus on September 8 after approving ₹126 crore capex for 134 acres in Kakinada. The stock has gained 50.46% YTD in CY2026. Neuland Laboratories Ltd. (NSE:

) could be in focus today, September 8, 2026, after the company announced a major expansion move in Andhra Pradesh. The company’s Board has approved ₹126 crore in capital expenditure to purchase approximately 134 acres of land in Kakinada. Neuland also has a right of first refusal to acquire another contiguous parcel of around 66 acres, potentially taking its total landholding at the location to nearly 200 acres. According to the company, the land acquisition is intended to support its future expansion plans. The announcement comes after a strong run in the stock. Neuland Laboratories shares closed at ₹22,870 on September 7, up 0.93% for the day. The stock’s 52-week high stands at ₹23,881. Neuland Laboratories has gained an impressive 50.46% year-to-date in CY2026, while rising 13.55% over the past month. However, the stock declined 2.35% during the last one week. With a market capitalisation of ₹29,368 crore and a P/E ratio of 59, investors may watch whether the expansion announcement acts as another catalyst for the stock in the coming sessions. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.